bioMérieux
@biomerieux.com
We are global leader in in vitro diagnostics committed to improving public health worldwide. Since 1963, our innovative diagnostics solutions help healthcare professionals make confident decisions to enhance patient outcomes.
February 5, 2026 at 8:24 AM
💡Key insights:
• Detects very low troponin for improved early AMI diagnosis.
• Enables near-patient testing, some using capillary blood.
• Lab-grade performance with faster turnaround (8–20 min).
• Simplifies maintenance and supports emergency workflows.
#MedSky #CardioSky
• Detects very low troponin for improved early AMI diagnosis.
• Enables near-patient testing, some using capillary blood.
• Lab-grade performance with faster turnaround (8–20 min).
• Simplifies maintenance and supports emergency workflows.
#MedSky #CardioSky
November 26, 2025 at 8:38 AM
💡Key insights:
• Detects very low troponin for improved early AMI diagnosis.
• Enables near-patient testing, some using capillary blood.
• Lab-grade performance with faster turnaround (8–20 min).
• Simplifies maintenance and supports emergency workflows.
#MedSky #CardioSky
• Detects very low troponin for improved early AMI diagnosis.
• Enables near-patient testing, some using capillary blood.
• Lab-grade performance with faster turnaround (8–20 min).
• Simplifies maintenance and supports emergency workflows.
#MedSky #CardioSky